Present and potential therapy for allergic rhinitis: A review

BioDrugs

Volumn 14, Issue 6, 2000, Pages 371-387

  Reichmuth, Daniel ^a   Lockey, Richard F ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; BECLOMETASONE DIPROPIONATE; CETIRIZINE; CORTICOSTEROID DERIVATIVE; DESLORATADINE; DRUG METABOLITE; EBASTINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE PROPIONATE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E ANTIBODY; IMMUNOLOGICAL ADJUVANT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MIZOLASTINE; MOMETASONE FUROATE; NORASTEMIZOLE; OLIGONUCLEOTIDE; PEPTIDE DERIVATIVE; TERFENADINE; TRIAMCINOLONE;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ATOPY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; REVIEW; SEDATION; SIDE EFFECT;

EID: 0034495015     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200014060-00003     Document Type: Review

References (5)

1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prev alence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351: 1225-32
2. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991; 46: 895-901
3. Woodwell DA. National Ambulatory Medical Care Survey: 1997 summary. Advance data from vital and health statistics; no. 305. Hyattsville (MD): National Center for Health Statistics, 1999 May
4. Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997; 99(1): 22-7
5. Storms W, Meltzer EO, Nathan RA, et al. The economic impact of allergic rhinitis. J Allergy Clin Immunol 1997; 99 (2): S820-4